However, no data on enhancing radiosensitivity by combined inhibition of PI3K/Akt and GLUT-1 expression or suppression of expression of GLUT-1 via inhibition of the PI3K/Akt signaling pathway in carcinomas have been reported previously. This evidence concerns the gene SLC2A1 and carcinoma.